These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 31792817)
21. How MR1 Presents a Pathogen Metabolic Signature to Mucosal-Associated Invariant T (MAIT) Cells. McWilliam HEG; Villadangos JA Trends Immunol; 2017 Sep; 38(9):679-689. PubMed ID: 28688841 [TBL] [Abstract][Full Text] [Related]
22. Human liver CD8 Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824 [TBL] [Abstract][Full Text] [Related]
23. Interactions Between MAIT Cells and Dendritic Cells. Salio M; Cerundolo V Methods Mol Biol; 2020; 2098():125-139. PubMed ID: 31792819 [TBL] [Abstract][Full Text] [Related]
24. MR1 antigen presentation to MAIT cells: new ligands, diverse pathways? McWilliam HE; Villadangos JA Curr Opin Immunol; 2018 Jun; 52():108-113. PubMed ID: 29754112 [TBL] [Abstract][Full Text] [Related]
25. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells. Lepore M; Lewinsohn DA; Lewinsohn DM Mol Immunol; 2021 Feb; 130():64-68. PubMed ID: 33360378 [TBL] [Abstract][Full Text] [Related]
26. Diverse MR1-restricted T cells in mice and humans. Koay HF; Gherardin NA; Xu C; Seneviratna R; Zhao Z; Chen Z; Fairlie DP; McCluskey J; Pellicci DG; Uldrich AP; Godfrey DI Nat Commun; 2019 May; 10(1):2243. PubMed ID: 31113973 [TBL] [Abstract][Full Text] [Related]
27. Potent Immunomodulators Developed from an Unstable Bacterial Metabolite of Vitamin B2 Biosynthesis. Mak JYW; Rivero RJD; Hoang HN; Lim XY; Deng J; McWilliam HEG; Villadangos JA; McCluskey J; Corbett AJ; Fairlie DP Angew Chem Int Ed Engl; 2024 Jul; 63(31):e202400632. PubMed ID: 38679861 [TBL] [Abstract][Full Text] [Related]
28. MR1-Restricted T Cells Are Unprecedented Cancer Fighters. Vacchini A; Chancellor A; Spagnuolo J; Mori L; De Libero G Front Immunol; 2020; 11():751. PubMed ID: 32411144 [TBL] [Abstract][Full Text] [Related]
29. MR1-restricted T cells: the new dawn of cancer immunotherapy. Wang Z; Wang M; Chen J; Zhang L; Zhang L; Yu L Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185693 [TBL] [Abstract][Full Text] [Related]
35. Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU). Li K; Vorkas CK; Chaudhry A; Bell DL; Willis RA; Rudensky A; Altman JD; Glickman MS; Aubé J PLoS One; 2018; 13(2):e0191837. PubMed ID: 29401462 [TBL] [Abstract][Full Text] [Related]
36. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells. Zumwalde NA; Haag JD; Gould MN; Gumperz JE Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917 [TBL] [Abstract][Full Text] [Related]
37. Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation. Suliman S; Kjer-Nielsen L; Iwany SK; Lopez Tamara K; Loh L; Grzelak L; Kedzierska K; Ocampo TA; Corbett AJ; McCluskey J; Rossjohn J; León SR; Calderon R; Lecca-Garcia L; Murray MB; Moody DB; Van Rhijn I J Immunol; 2022 Mar; 208(6):1389-1395. PubMed ID: 35246495 [TBL] [Abstract][Full Text] [Related]
38. Virus-Mediated Suppression of the Antigen Presentation Molecule MR1. McSharry BP; Samer C; McWilliam HEG; Ashley CL; Yee MB; Steain M; Liu L; Fairlie DP; Kinchington PR; McCluskey J; Abendroth A; Villadangos JA; Rossjohn J; Slobedman B Cell Rep; 2020 Mar; 30(9):2948-2962.e4. PubMed ID: 32130899 [TBL] [Abstract][Full Text] [Related]